What does my result mean?
A relevant biomarker is found
Biomarkers detected (such as HER2-positive, MSI-H, KRAS mutation, BRCA mutation, etc) may help inform treatment, further testing or a clinical trial discussion.
No matching biomarker is found
This does not mean there are no treatment options.
The meaning is uncertain
Some findings are not currently used to guide treatment and may need future review.
A positive biomarker result does not automatically mean that you have a particular treatment available. And a negative result does not mean that there are no treatment options. A biomarker result is part of the decision, it may help the healthcare team understand whether a particular treatment may be suitable, whether your cancer may respond to a specific targeted treatment or immunotherapy, whether a clinical trial may be relevant, how your cancer may behave or change over time, or whether additional testing may be needed. However, your healthcare team will consider your biomarker result together with your cancer type, stage, previous treatments, overall health and personal circumstances when discussing your treatment options.
Learn more about biomarkers in your type of cancer
Does my result mean I have an inherited genetic mutation?
Not necessarily. Some biomarker tests look for genetic changes in cancer cells. These changes can develop during cancer and may not be inherited or passed on to your children. In some situations, your healthcare team may recommend a separate genetic test to find out whether a genetic change was inherited.
Biomarker testing and genetic testing: what’s the difference?
Biomarker testing looks for specific features of a cancer. These can include changes in genes, proteins, or other molecules found in tumour cells. The results can help doctors understand the cancer and decide which treatments may be suitable.
Genetic testing looks at the genes you were born with. It can identify inherited changes (called germline mutations) that may increase your risk of developing certain cancers. These changes can sometimes also be relevant to your family members.
In simple terms: Biomarker testing asks “What is happening in my cancer?” while genetic testing asks “Do I have an inherited genetic change that may affect my cancer risk?”
